http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1209958-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B-
filingDate 1968-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1970-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1209958-A
titleOfInvention RESOLUTION OF alpha-AMINOCAPROLACTAM AND N-CARBAMOYL-VALINE
abstract 1,209,958. Optically active salts. TANABE SEIYAKU CO. Ltd. 15 Feb., 1968 [16 Feb., 1967], No. 7358/68. Heading C2C. The invention comprises novel optically active salts of an optical enantiomorph of α-aminocaprolactam and an optical enantiomorph of N-carbamoyl-valine e.g. D-α-aminocaprolactam N-carbamoyl-L-valinate. The salts may be prepared in the course of resolution of a racemic mixture of α-aminocaprolactam by reacting with an optically active enantiomer of N-carbamoyl-valine or from the resolution of racemic N-carbamoyl-valine with an optically active enantiomer of α-amino-caprolactam. The enantiomers may be recovered by treating the diastereoisomers with an acid e.g. HC1.
priorityDate 1967-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5151292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439823

Total number of triples: 18.